# Evaluation of Exparel Adductor Canal Field Block for Pain Control After ACL Reconstruction

> **NCT04764916** · PHASE3 · UNKNOWN · sponsor: **Carilion Clinic** · enrollment: 60 (estimated)

## Conditions studied

- Anterior Cruciate Ligament Tear
- Pain, Postoperative
- Opioid Use

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT04764916
- **Lead sponsor:** Carilion Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-16
- **Primary completion:** 2022-02-16
- **Final completion:** 2022-03-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04764916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04764916, "Evaluation of Exparel Adductor Canal Field Block for Pain Control After ACL Reconstruction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04764916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*